ConductScience.org, home

Paper40693239

Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN.

Zhang Y and 16 others. J Natl Cancer Cent, 2025. Cited by 143 papers, by iCite.

Cite this record

ConductScience Library. Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. Papers, record 40693239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40693239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN.
PubMed
Journal
J Natl Cancer Cent
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
143
iCite
Relative citation ratio, by iCite
43.11, provisional
iCite
Revised in PubMed
2025-07-24
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYunmeng
2Ji YYuting
3Liu SSiwen
4Li JJingjing
5Wu JJie
6Jin QQianyun
7Liu XXiaomin
8Duan HHongyuan
9Feng ZZhuowei
10Liu YYa
11Zhang YYacong
12Lyu ZZhangyan
13Song FFangfang
14Song FFengju
15Yang LLei
16Liu HHong
17Huang YYubei

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT07344597Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast CancerResultsClinicalTrials.gov
NCT07367334Effects of MMV Exercise With and Without Verbal Guidance on Shoulder Movement, Fatigue, and Stress in Breast Cancer SurvivorsResultsClinicalTrials.gov

Download CSV of trials

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138762325Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.Lancet2024https://conductscience.org/library/papers/38762325PubMed
232679112Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study.Lancet2020https://conductscience.org/library/papers/32679112PubMed
336883419Breast cancer screening programmes and self-reported mammography use in European countries.Int J Cancer2023https://conductscience.org/library/papers/36883419PubMed
433691141The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases.Lancet Oncol2021https://conductscience.org/library/papers/33691141PubMed
531030667Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?Cancer Commun (Lond)2019https://conductscience.org/library/papers/31030667PubMed
622456983Breast cancer incidence trends in European women aged 20-39 years at diagnosis.Breast Cancer Res Treat2012https://conductscience.org/library/papers/22456983PubMed
737774721Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study.Lancet Glob Health2023https://conductscience.org/library/papers/37774721PubMed
831933580National Breast Screening Programs across Europe.Breast Care (Basel)2019https://conductscience.org/library/papers/31933580PubMed
917442911The decrease in breast-cancer incidence in 2003 in the United States.N Engl J Med2007https://conductscience.org/library/papers/17442911PubMed
1034002584Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030.Cancer Biol Med2021https://conductscience.org/library/papers/34002584PubMed
1128988610Trends and predictions to 2020 in breast cancer mortality in Europe.Breast2017https://conductscience.org/library/papers/28988610PubMed
1238572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1334062485European trends in breast cancer mortality, 1980-2017 and predictions to 2025.Eur J Cancer2021https://conductscience.org/library/papers/34062485PubMed
1424639443Temporal trends of main reproductive characteristics in ten urban and rural regions of China: the China Kadoorie biobank study of 300 000 women.Int J Epidemiol2014https://conductscience.org/library/papers/24639443PubMed
1532933761Landmark trials in the medical oncology management of early stage breast cancer.Semin Oncol2020https://conductscience.org/library/papers/32933761PubMed
1610793111Biologic characteristics of interval and screen-detected breast cancers.J Natl Cancer Inst2000https://conductscience.org/library/papers/10793111PubMed
1738000379Cancer screening in China: a steep road from evidence to implementation.Lancet Public Health2023https://conductscience.org/library/papers/38000379PubMed
1834278281Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns.EClinicalMedicine2021https://conductscience.org/library/papers/34278281PubMed
1912117397Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.JAMA2002https://conductscience.org/library/papers/12117397PubMed
2010580027Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.J Natl Cancer Inst1999https://conductscience.org/library/papers/10580027PubMed

See all 70 referencesDownload CSV of references

Cited by113

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.

PMIDTitleJournalYearIn PapersSource
42985087Burden, trends, and projections of prostate cancer: global cancer statistics (GLOBOCAN) estimates for 2024 and 2022.J Natl Cancer Cent2026https://conductscience.org/library/papers/42985087PubMed
42955935Reported clinical breast examination activity in Bangladesh, 2019-2025: Temporal trends, geographic variation, positivity, and reporting completeness.PLoS One2026https://conductscience.org/library/papers/42955935PubMed
42952764Harnessing marine polysaccharides for breast cancer therapy: ulvan synergizes with nano-selenium to induce programmed cell death through dual modulation of autophagy and apoptosis.Front Pharmacol2026https://conductscience.org/library/papers/42952764PubMed
42941599A Comparative Analysis of Women's Experiences with Cone Beam Breast CT and Digital Mammography in Australia.J Clin Med2026https://conductscience.org/library/papers/42941599PubMed
42923786Design and synthesis of 3-(1H-indol-3-yl)-N-(3,4,5-trimethoxyphenyl) acrylamide derivatives as anticancer agents.RSC Adv2026https://conductscience.org/library/papers/42923786PubMed
42877267Determinants of self-reported sustained breast cancer screening among women in Shenzhen, China: a study based on the health belief model.Front Public Health2026https://conductscience.org/library/papers/42877267PubMed
42830884VEGF-Leptin Crosstalk in Breast and Ovarian Cancer: Drivers of Angiogenesis and Progression.Cancer Manag Res2026https://conductscience.org/library/papers/42830884PubMed
42820989Development of ursolic acid-loaded cubosomal nanocarriers: enhanced dissolution, pharmacokinetics, bioavailability, and anticancer activity.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42820989PubMed
42798422In vivo assessment of broccoli extract based hydrogel in mitigating DMBA induced breast cancer in female mice.Front Oncol2026https://conductscience.org/library/papers/42798422PubMed
42786286Localized immunotherapy via dissolving microneedles for the prevention of breast cancer recurrence.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42786286PubMed
42755039Synthesis, Structural Characterization, and Investigation of Biological Effects of Novel Benzothiazole-Triazole Derivatives Designed as AKT Kinase Inhibitors.Chem Biol Drug Des2026https://conductscience.org/library/papers/42755039PubMed
42738331Comprehensive Genomic Profiling Reveals the Mutational Spectrum and Clinical Significance of BRCA1/2 and Other Cancer-Susceptibility Genes in Breast Cancer Patients from Southern Tunisia.Cancers (Basel)2026https://conductscience.org/library/papers/42738331PubMed
42717684Knowledge of early signs and risk factors, and attitude towards breast cancer among women in Dodoma, Tanzania: a community-based cross-sectional study.Future Sci OA2026https://conductscience.org/library/papers/42717684PubMed
42707088Comorbidity patterns and risk of breast cancer: a case-control study exploring interaction with BMI using latent class analysis.Front Oncol2026https://conductscience.org/library/papers/42707088PubMed
42699527Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance.Cancer Pathog Ther2026https://conductscience.org/library/papers/42699527PubMed
42670587Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential.FASEB J2026https://conductscience.org/library/papers/42670587PubMed
42652383Breast Cancer Knowledge and Screening Barriers Among Female University Students of Pakistan.Int J Environ Res Public Health2026https://conductscience.org/library/papers/42652383PubMed
42651307Algorithmic Prognostication in Female Oncofertility Counseling: Ethical Challenges of Bias, Autonomy, and Predictive Uncertainty.Healthcare (Basel)2026https://conductscience.org/library/papers/42651307PubMed
42605911Venom-Derived Peptides in Breast Cancer: Pharmacological Mechanisms and Medicinal Chemistry-Guided Translational Development.Arch Pharm (Weinheim)2026https://conductscience.org/library/papers/42605911PubMed
42591577Emerging role of human epidermal growth factor 2-low status in the prognosis and management of triple-negative breast cancer: a narrative review.Transl Cancer Res2026https://conductscience.org/library/papers/42591577PubMed

See all 113 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40693239

GET https://conductscience.org/api/papers/v1/40693239/references?page=2